Fusion expression and immunogenicity of EHEC EspA-Stx2Al protein: Implications for the vaccine development

Journal of Microbiology

Volumn 47, Issue 4, 2009, Pages 498-505

  Cheng, Yan ^a   Feng, Youjun ^a,b   Luo, Ping ^a   Gu, Jiang ^a   Yu, Shu ^a   Zhang, Wei jun ^a   Liu, Yan qing ^a   Wang, Qing xu ^a   Zou, Quan ming ^a   Mao, Xu hu ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

EHEC O157:H7; EspA; Fusion protein; Stx2A1; Vaccine

Indexed keywords

BACTERIAL VACCINE; BACTERIUM ANTIBODY; ESCHERICHIA COLI PROTEIN; ESPA PROTEIN, E COLI; HYBRID PROTEIN; VEROTOXIN 2;

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; ENTEROHEMORRHAGIC ESCHERICHIA COLI; ESCHERICHIA COLI INFECTION; GENE EXPRESSION; GENETICS; HELA CELL; HUMAN; IMMUNOLOGY; MICROBIOLOGY; MOUSE; PROTEIN ENGINEERING;

ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL VACCINES; ENTEROHEMORRHAGIC ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI PROTEINS; GENE EXPRESSION; HELA CELLS; HUMANS; MICE; MICE, INBRED BALB C; PROTEIN ENGINEERING; RECOMBINANT FUSION PROTEINS; SHIGA TOXIN 2;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; MUS; PROKARYOTA;

EID: 70350146662     PISSN: 12258873     EISSN: 12258873     Source Type: Journal    
DOI: 10.1007/s12275-009-0116-8     Document Type: Article

References (31)

1. Akiyoshi, D.E., C.M. Rich, S. O'sullivan-Murphy, L. Richard, J. Dilo, A. Donohue-Rolfe, A.S. Sheoran, S. Chapman-Bonofiglio, and S. Tzipori. 2005. Characterization of a human monoclonal antibody against Shiga toxin 2 expressed in Chinese hamster ovary cells. Infect. Immun. 73, 4054-4061.
2. Bielaszewska, M., R. Kock, A.W. Friedrich, C. von Eiff, L.B. Zimmerhackl, H. Karch, and A. Mellmann. 2007. Shiga toxin-mediated hemolytic uremic syndrome: time to change the diagnostic paradigm? PLoS ONE. 2, e1024.
3. Dziva, F., I. Vlisidou, V.F. Crepin, T.S. Wallis, G. Frankel, and M.P. Stevens. 2007. Vaccination of calves with EspA, a key colonisation factor of Escherichia coli O157:H7, induces antigen-specific humoral responses but does not confer protection against intestinal colonisation. Vet. Microbiol. 123, 254-261.
4. Feng, Y., F. Zheng, X. Pan, W. Sun, C. Wang, Y. Dong, A.P. Ju, J. Ge, D. Liu, C. Liu, J. Yan, J. Tang, and G.F. Gao. 2007. Existence and characterization of allelic variants of Sao, a newly identified surface protein from Streptococcus suis. FEMS Microbiol. Lett. 275, 80-88.
5. Fraser, M.E., M. Fujinaga, M.M. Cherney, A.R. Melton-Celsa, E.M. Twiddy, A.D. O'Brien, and M.N. James. 2004. Structure of shiga toxin type 2 (Stx2) from Escherichia coli O157:H7. J. Biol. Chem. 279, 27511-27517.
6. Jarvis, K.G. and J.B. Kaper. 1996. Secretion of extracellular proteins by enterohemorrhagic Escherichia coli via a putative type III secretion system. Infect. Immun. 64, 4826-4829.
7. Karmali, M.A., B.T. Steele, M. Petric, and C. Lim. 1983. Sporadic cases of haemolytic-uraemic syndrome associated with faecal cytotoxin and cytotoxin-producing Escherichia coli in stools. Lancet 1, 619-620.
8. Karpman, D., Z.D. Bekassy, A.C. Sjogren, M.S. Dubois, M.A. Karmali, M. Mascarenhas, K.G. Jarvis, L.J. Gansheroff, A.D. O'Brien, G.S. Arbus, and J.B. Kaper. 2002. Antibodies to intimin and Escherichia coli secreted proteins A and B in patients with enterohemorrhagic Escherichia coli infections. Pediatr. Nephrol. 17, 201-211.
9. Kato, T., D. Hamada, T. Fukui, M. Hayashi, T. Honda, Y. Murooka, and I. Yanagihara. 2005. A pH-dependent conformational change in EspA, a component of the Escherichia coli O157:H7 type III secretion system. Febs J. 272, 2773-2783.
10. Kenny, B., L.C. Lai, B.B. Finlay, and M.S. Donnenberg. 1996. EspA, a protein secreted by enteropathogenic Escherichia coli, is required to induce signals in epithelial cells. Mol. Microbiol. 20, 313-323.
11. Kuczius, T., M. Bielaszewska, A.W. Friedrich, and W. Zhang. 2004. A rapid method for the discrimination of genes encoding classical Shiga toxin (Stx) 1 and its variants, Stx1c and Stx1d, in Escherichia coli. Mol. Nutr. Food Res. 48, 515-521.
12. La Ragione, R.M., S. Patel, B. Maddison, M.J. Woodward, A. Best, G.C. Whitelam, and K.C. Gough. 2006. Recombinant anti-EspA antibodies block Escherichia coli O157:H7-induced attaching and effacing lesions in vitro. Microb. Infect. 8, 426-433.
13. Louise, C.B. and T.G. Obrig. 1992. Shiga toxin-associated hemolytic uremic syndrome: combined cytotoxic effects of shiga toxin and lipopolysaccharide (endotoxin) on human vascular endothelial cells in vitro. Infect. Immun. 60, 1536-1543.
14. Ma, Y., X. Mao, J. Li, H. Li, Y. Feng, H. Chen, P. Luo, J. Gu, S. Yu, H. Zeng, G. Guo, K. Yang, and Q. Zou. 2008. Engineering an anti-Stx2 antibody to control severe infections of EHEC O157:H7. Immunol. Lett. 121, 110-115.
15. Marcato, P., T.P. Griener, G.L. Mulvey, and G.D. Armstrong. 2005. Recombinant shiga toxin B-subunit-keyhole limpet hemocyanin conjugate vaccine protects mice from Shigatoxemia. Infect. Immun. 73, 6523-6529.
16. Marcato, P., G. Mulvey, R.J. Read, K. Vander Helm, P.N. Nation, and G.D. Armstrong. 2001. Immunoprophylactic potential of cloned Shiga toxin 2 B subunit. J. Infect. Dis. 183, 435-443.
17. Matise, I., N.A. Cornick, S.L. Booher, J.E. Samuel, B.T. Bosworth, and H.W. Moon. 2001. Intervention with Shiga toxin (Stx) antibody after infection by Stx-producing Escherichia coli. J. Infect. Dis. 183, 347-350.
18. Mukherjee, J., K. Chios, D. Fishwild, D. Hudson, S. O'Donnell, S.M. Rich, A. Donohue-Rolfe, and S. Tzipori. 2002. Human Stx2-specific monoclonal antibodies prevent systemic complications of Escherichia coli O157:H7 infection. Infect. Immun. 70, 612-619.
19. Perna, N.T., G.F. Mayhew, G. Posfai, S. Elliott, M.S. Donnenberg, J.B. Kaper, and F.R. Blattner. 1998. Molecular evolution of a pathogenicity island from enterohemorrhagic Escherichia coli O157:H7. Infect. Immun. 66, 3810-3817.
20. Ran, X.Q., H.Z. Wang, J.J. Liu, S. Li, and J.F. Wang. 2008. The immunogenicity of fusion protein linking the carboxyl terminus of the B subunit of Shiga toxin 2 to the B subunit of E. coli heat-labile enterotoxin. Vet. Microbiol. 127, 209-215.
21. Riley, L.W., R.S. Remis, S.D. Helgerson, H.B. McGee, J.G. Wells, B.R. Davis, R.J. Hebert, E.S. Olcott, L.M. Johnson, N.T. Hargrett, P.A. Blake, and M.L. Cohen. 1983. Hemorrhagic colitis associated with a rare Escherichia coli serotype. N. Engl. J. Med. 308, 681-685.
22. Ritchie, J.M., C.M. Thorpe, A.B. Rogers, and M.K. Waldor. 2003. Critical roles for stx2, eae, and tir in enterohemorrhagic Escherichia coli-induced diarrhea and intestinal inflammation in infant rabbits. Infect. Immun. 71, 7129-7139.
23. Roe, A.J., H. Yull, S.W. Naylor, M.J. Woodward, D.G. Smith, and D.L. Gally. 2003. Heterogeneous surface expression of EspA translocon filaments by Escherichia coli O157:H7 is controlled at the posttranscriptional level. Infect. Immun. 71, 5900-5909.
24. Russmann, H., H. Schmidt, J. Heesemann, A. Caprioli, and H. Karch. 1994. Variants of Shiga-like toxin II constitute a major toxin component in Escherichia coli O157 strains from patients with haemolytic uraemic syndrome. J. Med. Microbiol. 40, 338-343.
25. Sekiya, K., M. Ohishi, T. Ogino, K. Tamano, C. Sasakawa, and A. Abe. 2001. Supermolecular structure of the enteropathogenic Escherichia coli type III secretion system and its direct interaction with the EspA-sheath-like structure. Proc. Natl. Acad. Sci. USA 98, 11638-11643.
26. Takahashi, H., K. Sasaki, M. Takahashi, N. Shigemori, S. Honda, H. Arimitsu, S. Ochi, N. Ohara, and T. Tsuji. 2006. Mutant Escherichia coli enterotoxin as a mucosal adjuvant induces specific Th1 responses of CD4+ and CD8+ T cells to nasal killed-bacillus calmette-guerin in mice. Vaccine 24, 3591-3598.
27. Tarr, P.I., C.A. Gordon, and W.L. Chandler. 2005. Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome. Lancet 365, 1073-1086.
28. Wen, S.X., L.D. Teel, N.A. Judge, and A.D. O'Brien. 2006. Genetic toxoids of Shiga toxin types 1 and 2 protect mice against homologous but not heterologous toxin challenge. Vaccine 24, 1142-1148.
29. Yoshimura, K., J. Fujii, A. Tanimoto, T. Yutsudo, M. Kashimura, and S. Yoshida. 2000. Effects of Shiga toxin 2 on lethality, fetuses, delivery, and puerperal behavior in pregnant mice. Infect. Immun. 68, 2254-2258.
30. Yu, S., P. Luo, H.Z. Chen, H.X. Li, and X.H. Mao. 2007. Preparation and characterization of monoclonal antibody against enterohemorrhagic Escherichia coli O157:H7 EspA. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 23, 657-659.
31. Zhang, W., M. Bielaszewska, T. Kuczius, and H. Karch. 2002. Identification, characterization, and distribution of a Shiga toxin 1 gene variant (stx(1c)) in Escherichia coli strains isolated from humans. J. Clin. Microbiol. 40, 1441-1446.